New PET Imaging Agent Promises Improved Detection of Coronary Artery Disease and Reduced Radiation Exposure for Obese Patients
|
By MedImaging International staff writers Posted on 26 Apr 2016 |
|
A global leader in the development of diagnostic imaging agents has presented the results of a first Phase 3 study of a new PET imaging agent at the American College of Cardiology (ACC) Annual Scientific Session, in April 2016, in Chicago.
In the study, the new investigational Positron Emission Tomography (PET) imaging agent was compared to Myocardial Perfusion Imaging (MPI) using Single Photon Emission Computed Tomography (SPECT) to assess Coronary Artery Disease (CAD) in patients with a BMI of 30 or higher. Obesity can lead to an increased risk of stroke, heart disease, high blood pressure, or diabetes.
The flurpiridaz F 18 PET imaging agent was developed by Lantheus Medical Imaging (LMI; North Billerica, MA, USA), a company which develops, manufactures, and commercializes diagnostic imaging agents.
The results of the study showed that flurpiridaz F 18 could improve the detection of coronary artery disease in obese patients, compared to SPECT MPI, while at the same time reducing radiation exposure for the patients.
Cesare Orlandi, MD, CMO, Lantheus Medical Imaging, said, "The Phase 3 data sub- analysis presented at ACC show the advantages of flurpiridaz F 18 PET imaging for coronary artery disease detection in obese patients. Flurpiridaz F 18 PET imaging shows superiority over SPECT in an obese population and provides images with better quality, and less attenuation, which can lead to increased diagnostic certainty by physicians. We believe the improved diagnostic accuracy, utility in stress imaging, reduced radiation exposure and potential for quantification of coronary flow reserve provide great promise for flurpiridaz F 18 to become the diagnostic imaging tool of choice for evaluating coronary artery disease in obese patients.”
Related Links:
Lantheus Medical Imaging
In the study, the new investigational Positron Emission Tomography (PET) imaging agent was compared to Myocardial Perfusion Imaging (MPI) using Single Photon Emission Computed Tomography (SPECT) to assess Coronary Artery Disease (CAD) in patients with a BMI of 30 or higher. Obesity can lead to an increased risk of stroke, heart disease, high blood pressure, or diabetes.
The flurpiridaz F 18 PET imaging agent was developed by Lantheus Medical Imaging (LMI; North Billerica, MA, USA), a company which develops, manufactures, and commercializes diagnostic imaging agents.
The results of the study showed that flurpiridaz F 18 could improve the detection of coronary artery disease in obese patients, compared to SPECT MPI, while at the same time reducing radiation exposure for the patients.
Cesare Orlandi, MD, CMO, Lantheus Medical Imaging, said, "The Phase 3 data sub- analysis presented at ACC show the advantages of flurpiridaz F 18 PET imaging for coronary artery disease detection in obese patients. Flurpiridaz F 18 PET imaging shows superiority over SPECT in an obese population and provides images with better quality, and less attenuation, which can lead to increased diagnostic certainty by physicians. We believe the improved diagnostic accuracy, utility in stress imaging, reduced radiation exposure and potential for quantification of coronary flow reserve provide great promise for flurpiridaz F 18 to become the diagnostic imaging tool of choice for evaluating coronary artery disease in obese patients.”
Related Links:
Lantheus Medical Imaging
Ultrasound Needle Guidance System
SonoSite L25
Mobile X-Ray System
K4W
Digital Radiographic System
OMNERA 300M
Breast Localization System
MAMMOREP LOOP
Latest Nuclear Medicine News
- PET Imaging of Inflammation Predicts Recovery and Guides Therapy After Heart Attack
- Radiotheranostic Approach Detects, Kills and Reprograms Aggressive Cancers
- New Imaging Solution Improves Survival for Patients with Recurring Prostate Cancer
- PET Tracer Enables Same-Day Imaging of Triple-Negative Breast and Urothelial Cancers
- New Camera Sees Inside Human Body for Enhanced Scanning and Diagnosis
- Novel Bacteria-Specific PET Imaging Approach Detects Hard-To-Diagnose Lung Infections
- New Imaging Approach Could Reduce Need for Biopsies to Monitor Prostate Cancer
- Novel Radiolabeled Antibody Improves Diagnosis and Treatment of Solid Tumors
- Novel PET Imaging Approach Offers Never-Before-Seen View of Neuroinflammation
- Novel Radiotracer Identifies Biomarker for Triple-Negative Breast Cancer
- Innovative PET Imaging Technique to Help Diagnose Neurodegeneration
- New Molecular Imaging Test to Improve Lung Cancer Diagnosis
- Novel PET Technique Visualizes Spinal Cord Injuries to Predict Recovery
- Next-Gen Tau Radiotracers Outperform FDA-Approved Imaging Agents in Detecting Alzheimer’s
- Breakthrough Method Detects Inflammation in Body Using PET Imaging
- Advanced Imaging Reveals Hidden Metastases in High-Risk Prostate Cancer Patients
Channels
Radiography
view channel
X-Ray Breakthrough Captures Three Image-Contrast Types in Single Shot
Detecting early-stage cancer or subtle changes deep inside tissues has long challenged conventional X-ray systems, which rely only on how structures absorb radiation. This limitation keeps many microstructural... Read more
AI Generates Future Knee X-Rays to Predict Osteoarthritis Progression Risk
Osteoarthritis, a degenerative joint disease affecting over 500 million people worldwide, is the leading cause of disability among older adults. Current diagnostic tools allow doctors to assess damage... Read more
MRI
view channel
Novel Imaging Approach to Improve Treatment for Spinal Cord Injuries
Vascular dysfunction in the spinal cord contributes to multiple neurological conditions, including traumatic injuries and degenerative cervical myelopathy, where reduced blood flow can lead to progressive... Read more
AI-Assisted Model Enhances MRI Heart Scans
A cardiac MRI can reveal critical information about the heart’s function and any abnormalities, but traditional scans take 30 to 90 minutes and often suffer from poor image quality due to patient movement.... Read more
AI Model Outperforms Doctors at Identifying Patients Most At-Risk of Cardiac Arrest
Hypertrophic cardiomyopathy is one of the most common inherited heart conditions and a leading cause of sudden cardiac death in young individuals and athletes. While many patients live normal lives, some... Read more
Ultrasound
view channel
Wearable Ultrasound Imaging System to Enable Real-Time Disease Monitoring
Chronic conditions such as hypertension and heart failure require close monitoring, yet today’s ultrasound imaging is largely confined to hospitals and short, episodic scans. This reactive model limits... Read more
Ultrasound Technique Visualizes Deep Blood Vessels in 3D Without Contrast Agents
Producing clear 3D images of deep blood vessels has long been difficult without relying on contrast agents, CT scans, or MRI. Standard ultrasound typically provides only 2D cross-sections, limiting clinicians’... Read more
General/Advanced Imaging
view channel
New Algorithm Dramatically Speeds Up Stroke Detection Scans
When patients arrive at emergency rooms with stroke symptoms, clinicians must rapidly determine whether the cause is a blood clot or a brain bleed, as treatment decisions depend on this distinction.... Read more
3D Scanning Approach Enables Ultra-Precise Brain Surgery
Precise navigation is critical in neurosurgery, yet even small alignment errors can affect outcomes when operating deep within the brain. A new 3D surface-scanning approach now provides a radiation-free... Read more
Imaging IT
view channel
New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology
The global artificial intelligence (AI) in medical diagnostics market is expanding with early disease detection being one of its key applications and image recognition becoming a compelling consumer proposition... Read more
Industry News
view channel
GE HealthCare and NVIDIA Collaboration to Reimagine Diagnostic Imaging
GE HealthCare (Chicago, IL, USA) has entered into a collaboration with NVIDIA (Santa Clara, CA, USA), expanding the existing relationship between the two companies to focus on pioneering innovation in... Read more
Patient-Specific 3D-Printed Phantoms Transform CT Imaging
New research has highlighted how anatomically precise, patient-specific 3D-printed phantoms are proving to be scalable, cost-effective, and efficient tools in the development of new CT scan algorithms... Read more
Siemens and Sectra Collaborate on Enhancing Radiology Workflows
Siemens Healthineers (Forchheim, Germany) and Sectra (Linköping, Sweden) have entered into a collaboration aimed at enhancing radiologists' diagnostic capabilities and, in turn, improving patient care... Read more